tislelizumab,cisplatin,gemcitabine
beigene,novartis
['cisplatin', 'tislelizumab', 'gemcitabine', 'mibc']
final analysis results from a multicenter clinical study of tislelizumab combined with gemcitabine &amp; cisplatin as neoadjuvant therapy in patients with ct2-t4an0m0 #mibc. presentation by tianxin lin, md. #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology